Department of Medicine

February 15, 2018

Team finds stem cell transplant improves scleroderma survival

A new clinical trial by investigators at Vanderbilt University Medical Center (VUMC) and other leading medical centers found that an intensive transplant treatment using the patient’s own stem cells can improve survival and quality of life for patients with advanced scleroderma.

By VUMC News and Communications
February 15, 2018

Sepsis trial ranked No. 1 on critical care website

A clinical trial of an intervention for sepsis in patients in Zambia, led by Vanderbilt investigators, topped the list of 2017 trials featured by the website The Bottom Line.

By Leigh MacMillan
February 15, 2018

Vanderbilt’s Gamazon named visiting fellow at Cambridge University

Eric Gamazon, PhD, research instructor in the Division of Genetic Medicine at Vanderbilt University School of Medicine, is spending part of the academic year at Cambridge University in England as one of 40 Clare Hall Visiting Fellows.

By Bill Snyder
February 15, 2018

Bypass surgery program lauded

Vanderbilt University Medical Center (VUMC) was recognized as the No. 1 hospital in Tennessee for Medical Excellence in Coronary Bypass Surgery by CareChex in its 2018 Quality Rating Analysis.

By Jessica Pasley
February 12, 2018

Protecting transplanted lungs

Acetaminophen may offer a simple treatment to prevent tissue injury following lung transplant, Vanderbilt researchers have discovered.

By Leigh MacMillan
February 8, 2018

Event showcases REDCap’s data management versatility

Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe.

By Bill Snyder
February 8, 2018

Study seeks to boost breast tumor immune response

Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer.
By VUMC News and Communications
February 1, 2018

Study tracks therapy to slow idiopathic pulmonary fibrosis

Investigators in the Division of Allergy, Pulmonary and Critical Care have launched a pilot study to see if patients with idiopathic pulmonary fibrosis (IPF) can tolerate the addition of a commonly used antiviral drug to standard IPF treatments. The research team believes the drug may ultimately help slow progression of the chronic and progressive disease or reverse its course.
By Nancy Humphrey
January 25, 2018

Personalized drug prescribing program expands, upgrades

Vanderbilt University Medical Center (VUMC) has expanded and relaunched genetic testing to predict patient responses to drugs.
By Paul Govern
January 18, 2018

Study finds higher death rates in poor neighborhoods

Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans, new research shows. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.
By VUMC News and Communications
January 11, 2018

Wang set to lead cardiology association

Thomas Wang, MD, Gottlieb C. Friesinger II Professor of Cardiovascular Medicine and director of the Division of Cardiovascular Medicine, was recently named president-elect of the Association of Professors of Cardiology (APC) for 2018. He will subsequently serve as the president of the group in 2019.
By Jessica Pasley
January 9, 2018

Heart failure risk predicted by communities, not wealth

When buying and selling real estate, how often have you heard the realtor’s mantra — location, location, location? This is also the central theme of a recently released journal report on factors that can predict heart failure risk.
By Jessica Pasley
January 5, 2018

What you need to know about this year’s flu

Discover what strains are prominent, how effective this year’s vaccine is, and how hard the virus has hit Tennessee so far.
By VUMC News and Communications